Member Info for Kiwi_

Hi Laguna, bcl needs help with his research. I'm more than happy to help out. ;)

"SP back below 0.2p." PMSL, no Pet. It is actually called an Uncrossing Trade, if you look closely at the trade you will see the letters UT beside the trade. Here is a link to help you understand it a bit more, I hope this helps. ;)

Uncrossing Trade: During the auction period, there may be a point (or price) at which the best BID and best ASK match and a trade takes place. This trade on the London Stock Exchange (LSE) is known as an Uncrossing Trade.

https://help.stockopedia.com/technical-guide/prices/faqs/london-stock-exchange-quotes/

Another delayed 3 Million Buy

$13,5K Bitcoin Bull Awakens!

MMs getting cheeky this early in the day or is it just my Broker?

Interesting start to the week.

I'm hoping to add a few more either today or tomorrow. we only need just one piece of news to land and all eyes will be on Kibo

It's exciting to have the PPA, IPO and Katoro news that could land upon us at anytime now.

News cannot be far off now on three different fronts

Kibo and Kat could rise significantly next week, plenty of game changing news due in a very short time frame.

COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports
Among people with diabetes the mortality rate was 7.3%, more than three times that of the overall population.

https://care.diabetesjournals.org/content/43/7/1378

Here is the link:

https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

Here is the link:

https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes

Q: Do people with diabetes have a higher chance of experiencing serious complications from COVID-19?

A: People with diabetes do face a higher chance of experiencing serious complications from COVID-19. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus.

Stockopedia team comments on 8th OCT 2019Today 16:53
Argo Blockchain (LON:ARB)
Share price: 8.5p (+2%)
No. of shares: 294 million
Market cap: £25 million
Revenues increase 75% in Third Quarter
37 comments •1,187 Reads

This quirky little bitcoin operator changed its strategy from one which made no sense ("mining-as-a-service") to something much more reasonable (mining for its own account). Under this new strategy, it might actually succeed!

This update confirms £3.6 million of revenue from crypto mining in Q3, "at a mining margin of approximately 73%" (I guess this is the gross margin).

It is seeking to double the number of machines being used for production, adding 6,000 on to the current fleet.

Tactical change - it is going to regularly exchange crypto for fiat from now on, "to avoid additional exposure to Bitcoin pricing". Sounds reasonable. This will (marginally) reduce the volatility of its results.

My view - with its new strategy, and this tactical change, I think it's possible that this is a decent vehicle for PIs to gain crypto exposure (if that's what they're looking for).

For those who already trade shares, it might be simpler to buy a stake in this, versus using some other online wallet or trading facility.

If crypto coins turn out to be the investing equivalent of rat poison (Buffett) or "turds" (Munger), then shares in Argo can't be worth much less than the coins themselves will turn out to be.

I hadn't seen that mick-b, cheers for posting!

Here is the link:

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30272-2/fulltext#:~:text=23%20698%20in%2Dhospital%20COVID,with%20other%20types%20of%20diabetes.

My personal opinion......................... this will get fast tracked.

Interpretation:
The results of this nationwide analysis in England show that type 1 and type 2 diabetes were both independently associated with a significant increased odds of in-hospital death with COVID-19.

Findings:23?698 in-hospital COVID-19-related deaths occurred during the study period. A third occurred in people with diabetes: 7434 (31·4%) in people with type 2 diabetes, 364 (1·5%) in those with type 1 diabetes, and 69 (0·3%) in people with other types of diabetes. Unadjusted mortality rates per 100?000 people over the 72-day period were 27 (95% CI 27–28) for those without diabetes, 138 (124–153) for those with type 1 diabetes, and 260 (254–265) for those with type 2 diabetes. Adjusted for age, sex, deprivation, ethnicity, and geographical region, compared with people without diabetes, the odds ratios (ORs) for in-hospital COVID-19-related death were 3·51 (95% CI 3·16–3·90) in people with type 1 diabetes and 2·03 (1·97–2·09) in people with type 2 diabetes. These effects were attenuated to ORs of 2·86 (2·58–3·18) for type 1 diabetes and 1·80 (1·75–1·86) for type 2 diabetes when also adjusted for previous hospital admissions with coronary heart disease, cerebrovascular disease, or heart failure.